KCT0005690
Recruiting
未知
Comparison of the the Efficacy and Safety of durable polymer Novolimus-eluting Elixir DESyne X2™ Stent with Bioresorbable Polymer Sirolimus-Eluting Orsiro™ Stent in a Real World” patient population
Koera University Guro Hospital0 sites1,176 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Koera University Guro Hospital
- Enrollment
- 1176
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Patient over 20 years old
- •2\) Those who have objective ischemia symptoms such as Stable MI, Unstable MI, Acute or Recent MI or have objective evidence suggesting ischemia by electrocardiogram or functional tests (However, if coronary artery stenosis is more than 70%, no mention of objective ischemia is required)
- •3\) RVD 2\.5\-4\.0mm, Lesion that could be treated with stents.
- •4\) One or more epicardial coronary artery stenosis (above 50%)
- •5\) Patient who agree to sign on ICF.
Exclusion Criteria
- •1\) Patient with cardiogenic shock or SBP less than 80 mmHg.
- •2\) Persons with known hypersensitivity or contraindications to the following drugs and substances: Heparin, Aspirin, Clopidogrel, Prasugrel, Ticagrelor, Biolimus A9, Novolimus, Stainless steal, Cobalt chromium, Contrast agent (However, even subjects with hypersensitivity to contrast agents could be registered if they could be controlled by steroids and pheniramine, but those with known anaphylaxis are excluded.)
- •3\) Lactating and pregnant women. Women who wish to participate other clinical trials.
- •4\) Patient who life expectancy is less than 1 year
- •5\) Patients who disagree to participate in this clinical trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Comparison of efficacy and safety of different regimens of sublingual immunotherapy for Ragweed.EUCTR2011-001682-41-ITAZIENDA OSPEDALIERA L. SACCO (A.O. DI RILIEVO NAZIONALE)45
Completed
Phase 4
Comparison of efficacy and safety of Drotaverine Versus Mebeverine in Irritable Bowel SyndromeCTRI/2017/11/010529Walter Bushnell Pvt Ltd200
Not yet recruiting
Phase 4
Effectiveness and Safety of diabetic drugs in diabetic participantsCTRI/2024/07/071196Dr Manu Arya
Completed
Not Applicable
The comparative study of the efficacy and safety of Simeprevir sodium at investigational stage and after marketing authorizatioChronic hepatitis CJPRN-UMIN000045086Shimane University98
Completed
Phase 4
A clinical trial to study the effects of two doses of a drug Duloxetine in peripheral neuropathic pain in patients undergoing treatment with Taxane (anticancer drug).Health Condition 1: null- Taxane induced peripheral neuropathyCTRI/2017/02/007886Mysore Medical College and Research Institute44